Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Campylobacter infections in fattening pigs; excretion pattern and genetic diversity.
Weijtens MJ, Reinders RD, Urlings HA, Van der Plas J. Weijtens MJ, et al. J Appl Microbiol. 1999 Jan;86(1):63-70. doi: 10.1046/j.1365-2672.1999.00636.x. J Appl Microbiol. 1999. PMID: 10030012 Free article.
Discrimination of enterobacterial repetitive intergenic consensus PCR types of Campylobacter coli and Campylobacter jejuni by Fourier transform infrared spectroscopy.
Mouwen DJ, Weijtens MJ, Capita R, Alonso-Calleja C, Prieto M. Mouwen DJ, et al. Among authors: weijtens mj. Appl Environ Microbiol. 2005 Aug;71(8):4318-24. doi: 10.1128/AEM.71.8.4318-4324.2005. Appl Environ Microbiol. 2005. PMID: 16085819 Free PMC article.
Establishing a campylobacter-free pig population through a top-down approach.
Weijtens MJ, Urlings HA, Van der Plas J. Weijtens MJ, et al. Lett Appl Microbiol. 2000 Jun;30(6):479-84. doi: 10.1046/j.1472-765x.2000.00750.x. Lett Appl Microbiol. 2000. PMID: 10849280 Free article.
Prevalence of campylobacter in pigs during fattening; an epidemiological study.
Weijtens MJ, Bijker PG, Van der Plas J, Urlings HA, Biesheuvel MH. Weijtens MJ, et al. Vet Q. 1993 Dec;15(4):138-43. doi: 10.1080/01652176.1993.9694392. Vet Q. 1993. PMID: 7907195
The transmission of campylobacter in piggeries; an epidemiological study.
Weijtens MJ, van der Plas J, Bijker PG, Urlings HA, Koster D, van Logtestijn JG, Huis in't Veld JH. Weijtens MJ, et al. J Appl Microbiol. 1997 Dec;83(6):693-8. doi: 10.1046/j.1365-2672.1997.00301.x. J Appl Microbiol. 1997. PMID: 9449807 Free article.
Needs assessment for the use of vaccination.
Weijtens M, Maurice H, Van Langen H, Koch G. Weijtens M, et al. Dev Biol (Basel). 2007;130:85. Dev Biol (Basel). 2007. PMID: 18411938 No abstract available.
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
Baden LR, Liu J, Li H, Johnson JA, Walsh SR, Kleinjan JA, Engelson BA, Peter L, Abbink P, Milner DA Jr, Golden KL, Viani KL, Stachler MD, Chen BJ, Pau MG, Weijtens M, Carey BR, Miller CA, Swann EM, Wolff M, Loblein H, Seaman MS, Dolin R, Barouch DH. Baden LR, et al. J Infect Dis. 2015 Feb 15;211(4):518-28. doi: 10.1093/infdis/jiu485. Epub 2014 Aug 26. J Infect Dis. 2015. PMID: 25165165 Free PMC article. Clinical Trial.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Baden LR, Karita E, Mutua G, Bekker LG, Gray G, Page-Shipp L, Walsh SR, Nyombayire J, Anzala O, Roux S, Laher F, Innes C, Seaman MS, Cohen YZ, Peter L, Frahm N, McElrath MJ, Hayes P, Swann E, Grunenberg N, Grazia-Pau M, Weijtens M, Sadoff J, Dally L, Lombardo A, Gilmour J, Cox J, Dolin R, Fast P, Barouch DH, Laufer DS; B003-IPCAVD004-HVTN091 Study Group. Baden LR, et al. Ann Intern Med. 2016 Mar 1;164(5):313-22. doi: 10.7326/M15-0880. Epub 2016 Feb 2. Ann Intern Med. 2016. PMID: 26833336 Free PMC article. Clinical Trial.
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys.
Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, Dugast AS, Alter G, Ferguson M, Li W, Earl PL, Moss B, Giorgi EE, Szinger JJ, Eller LA, Billings EA, Rao M, Tovanabutra S, Sanders-Buell E, Weijtens M, Pau MG, Schuitemaker H, Robb ML, Kim JH, Korber BT, Michael NL. Barouch DH, et al. Cell. 2013 Oct 24;155(3):531-9. doi: 10.1016/j.cell.2013.09.061. Epub 2013 Oct 24. Cell. 2013. PMID: 24243013 Free PMC article.
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19).
Barouch DH, Tomaka FL, Wegmann F, Stieh DJ, Alter G, Robb ML, Michael NL, Peter L, Nkolola JP, Borducchi EN, Chandrashekar A, Jetton D, Stephenson KE, Li W, Korber B, Tomaras GD, Montefiori DC, Gray G, Frahm N, McElrath MJ, Baden L, Johnson J, Hutter J, Swann E, Karita E, Kibuuka H, Mpendo J, Garrett N, Mngadi K, Chinyenze K, Priddy F, Lazarus E, Laher F, Nitayapan S, Pitisuttithum P, Bart S, Campbell T, Feldman R, Lucksinger G, Borremans C, Callewaert K, Roten R, Sadoff J, Scheppler L, Weijtens M, Feddes-de Boer K, van Manen D, Vreugdenhil J, Zahn R, Lavreys L, Nijs S, Tolboom J, Hendriks J, Euler Z, Pau MG, Schuitemaker H. Barouch DH, et al. Lancet. 2018 Jul 21;392(10143):232-243. doi: 10.1016/S0140-6736(18)31364-3. Epub 2018 Jul 6. Lancet. 2018. PMID: 30047376 Free PMC article. Clinical Trial.
Feedback